Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome.

BACKGROUND: Acute respiratory distress syndrome (ARDS) is a major cause of mortality in intensive care patients and lacks effective treatments. A previous randomised controlled Phase II trial suggested that an intravenous (i.v.) infusion of salbutamol may be beneficial, as it reduced extravascular l...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Health Technol Assess
Main Authors: Gates, S, Perkins, G D, Lamb, S E, Kelly, C, Thickett, D R, Young, J D, McAuley, D F, Snaith, C, McCabe, C, Hulme, C T, Gao Smith, F
Formato: Artigo
Idioma:Inglês
Publicado: NIHR Journals Library 2013
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4781532/
https://ncbi.nlm.nih.gov/pubmed/24028755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta17380
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares